Se-cure is a clinical stage & revenues generating, research-driven pharmaceutical company, which has developed a proprietary platform for the discovery, development and scaling of therapies from botanical origin. Founded in 1997, Se-cure processes natural complex of biochemical compounds as found in the original plant, as a basis for designing therapies which selectively target specific tissues, while leaving other tissues intact.
Implementing proprietary botanical drug development and scaling technologies, Se-cure  introduces novel biochemical agents characterized by functionally selective mechanisms of action in the target tissues providing safe and effective solutions to medical needs.


The information on this site is outdated as we are currently updating our websites
including this one. We advise you to send us an e-mail to get information on
the exciting Femarelle's line extension which will be launched in September
2016.

We thank you for your patience and are looking
forward to hear from you through: info@se-curepharma.com

Se-cure is proud to take part in the CPhI exhibition rated as the European leading global,pharma expo next October in Barcelona

Home   |   About   |   R&D   |   Pipeline   |   Media   |   Investors   |   Contact